Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Atyr Pharma Inc (LIFE)

Atyr Pharma Inc (LIFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 116,534
  • Shares Outstanding, K 58,560
  • Annual Sales, $ 10,390 K
  • Annual Income, $ -45,340 K
  • 60-Month Beta 1.25
  • Price/Sales 268.75
  • Price/Cash Flow N/A
  • Price/Book 0.94
Trade LIFE with:

Options Overview Details

View History
  • Implied Volatility 119.99% ( -12.00%)
  • Historical Volatility 92.63%
  • IV Percentile 42%
  • IV Rank 14.05%
  • IV High 748.29% on 12/06/23
  • IV Low 17.30% on 03/23/23
  • Put/Call Vol Ratio 0.02
  • Today's Volume 147
  • Volume Avg (30-Day) 99
  • Put/Call OI Ratio 0.04
  • Today's Open Interest 1,937
  • Open Int (30-Day) 1,640

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.29
  • Growth Rate Est. (year over year) +344,582.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5500 +26.13%
on 03/14/24
2.1162 -7.62%
on 02/20/24
-0.0650 (-3.22%)
since 02/16/24
3-Month
1.2800 +52.73%
on 12/21/23
2.1162 -7.62%
on 02/20/24
+0.6850 (+53.94%)
since 12/18/23
52-Week
1.0801 +81.00%
on 11/13/23
2.6999 -27.59%
on 05/15/23
+0.0750 (+3.99%)
since 03/17/23

Most Recent Stories

More News
Atyr Pharma: Q4 Earnings Snapshot

Atyr Pharma: Q4 Earnings Snapshot

LIFE : 1.9550 (-1.76%)
Atyr Pharma: Q3 Earnings Snapshot

Atyr Pharma: Q3 Earnings Snapshot

LIFE : 1.9550 (-1.76%)
Atyr Pharma: Q2 Earnings Snapshot

Atyr Pharma: Q2 Earnings Snapshot

LIFE : 1.9550 (-1.76%)
Atyr Pharma (LIFE) Reports Q1 Loss, Misses Revenue Estimates

Atyr Pharma (LIFE) delivered earnings and revenue surprises of 25.64% and 100%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

LIFE : 1.9550 (-1.76%)
AADI : 2.12 (-2.30%)
Atyr Pharma: Q1 Earnings Snapshot

Atyr Pharma: Q1 Earnings Snapshot

LIFE : 1.9550 (-1.76%)
Atyr Pharma (LIFE) Reports Q4 Loss, Tops Revenue Estimates

Atyr Pharma (LIFE) delivered earnings and revenue surprises of 45.83% and 592.40%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

LIFE : 1.9550 (-1.76%)
TSVT : 4.19 (+4.49%)
Atyr Pharma: Q4 Earnings Snapshot

Atyr Pharma: Q4 Earnings Snapshot

LIFE : 1.9550 (-1.76%)
Atyr Pharma (LIFE) Upgraded to Buy: Here's What You Should Know

Atyr Pharma (LIFE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

LIFE : 1.9550 (-1.76%)
Atyr Pharma (LIFE) Reports Q3 Loss, Lags Revenue Estimates

Atyr Pharma (LIFE) delivered earnings and revenue surprises of -2.22% and 100%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

LIFE : 1.9550 (-1.76%)
ROIV : 9.87 (-2.66%)
Atyr Pharma: Q3 Earnings Snapshot

Atyr Pharma: Q3 Earnings Snapshot

LIFE : 1.9550 (-1.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

aTyr Pharma, Inc. is a bio-therapeutics company. The Company is involved in the discovery and development of medicines for severe, rare diseases of physiological modulators. aTyr Pharma, Inc. is a based in SAN DIEGO, United States.

See More

Key Turning Points

3rd Resistance Point 2.1512
2nd Resistance Point 2.0906
1st Resistance Point 2.0228
Last Price 1.9550
1st Support Level 1.8944
2nd Support Level 1.8338
3rd Support Level 1.7660

See More

52-Week High 2.6999
Fibonacci 61.8% 2.0811
Last Price 1.9550
Fibonacci 50% 1.8900
Fibonacci 38.2% 1.6989
52-Week Low 1.0801

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar